Shifts in striatal responsivity evoked by chronic stimulation of dopamine and glutamate systems

Brain

Volumn 125, Issue 10, 2002, Pages 2353-2363

  Canales, J J ^a,b   Capper Loup, C ^a,c   Hu, D ^a,d   Choe, E S ^a,e   Upadhyay, U ^a   Graybiel, A M ^a,f  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITAT JAUME I   (Spain)

^c UNIVERSITY OF BERN   (Switzerland)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e Chosun University   (South Korea)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Basal ganglia; Dopamine; Glutamate; Motor cortex; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; COCAINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMINE; NEUROTRANSMITTER; PROTEIN FOS;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; GENE EXPRESSION; MOTOR CORTEX; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0036787596     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf239     Document Type: Article

References (50)

1. Andersson M, Hilbertson A, Cenci MA. Striatal fosB expression is causally linked with I-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol Dis 1999; 6: 461-74.
2. Berretta S, Robertson HA, Graybiel AM. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J Neurophysiol 1992; 68: 767-77.
3. Berretta S, Parthasarathy HB, Graybiel AM. Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J Neurosci 1997; 17: 4752-63.
4. Berretta S, Sachs Z, Graybiel AM. Cortically driven Fos induction in the striatum is amplified by local dopamine D2-class receptor blockade. Eur J Neurosci 1999; 11: 4309-19.
5. Blanchet PJ, Papa SM, Metman LV, Mouradian MM, Chase TN. Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease. [Review]. Neurosci Biobehav Rev 1997; 21: 447-53.
6. Calabresi P, Saiardi A, Pisani A, Baik JH, Centonze D, Mercuri NB, et al. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J Neurosci 1997; 17: 4536-44.
7. Calabresi P, Centonze D, Gubellini P, Marfia GA, Bernardi G. Glutamate-triggered events inducing corticostriatal long-term depression. J Neurosci 1999; 19: 6102-10.
8. Canales JJ, Graybiel AM. Patterns of gene expression and behavior induced by chronic dopamine treatments. [Review]. Ann Neurol 2000a; 47 (4 Suppl 1): S53-9.
9. Canales JJ, Graybiel AM. A measure of striatal function predicts motor stereotypy. Nat Neurosci 2000b; 3: 377-83.
10. Carlsson M, Carlsson A, Interactions between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease. [Review]. Trends Neurosci 1990; 13: 272-6.
11. Cartmell J, Schoepp DD. Regulation of neurotransmitter release by metabotropic glutamate receptors. [Review]. J Neurochem 2000; 75: 889-907.
12. Cenci MA, Tranberg A, Andersson M, Hilbertson A. Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-DOPA treatment. Neuroscience 1999; 94: 515-27.
13. Cepeda C, Hurst RS, Altemus KL, Flores-Hernandez J, Calvert CR, Jokel ES, et al. Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol 2001; 85: 659-70,
14. Chase TN, Oh JD, Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. [Review]. Trends Neurosci 2000; 23 (10 Suppl): S86-91.
15. Chergui K, Svenningsson P, Nomikos GG, Gonon F, Fredholm BB, Svennson TH. Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle. Eur J Neurosci 1997; 9: 2370-82.
16. Fu L, Beckstead RM. Cortical stimulation induces fos expression in striatal neurons. Neuroscience 1992; 46: 329-34.
17. Ghasemzadeh MB, Nelson LC, Lu XY, Kalivas PW. Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment. J Neurochem 1999; 72: 157-65.
18. Graybiel AM, Canales JJ, Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. [Review]. Trends Neurosci 2000; 23 (10 Suppl): S71-7.
19. Greenamyre JT. Glutamatergic influences on the basal ganglia. [Review]. Clin Neuropharmacol 2001; 24: 65-70.
20. Greenberg BD, Ziemann U, Cora-Locatelli G, Harmon A, Murphy DL, Keel JC, et al. Altered cortical excitability in obsessivecompulsive disorder. Neurology 2000; 54: 142-7.
21. Hiroi N, Graybiel AM. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J Comp Neurol 1996; 374: 70-83.
22. Hope BT, Nye HE, Kelz MB, Self DW, Iadarola MJ, Nakabeppu Y, et al. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 1994; 13: 1235-44.
23. Huber J, Darling S, Park K, Soliman KF. Altered responsiveness to stress and NMDA following prenatal exposure to cocaine. Physiol Behav 2001; 72: 181-8.
24. Hyman SE, Cole RL, Konradi C, Kosofsky BE. Dopamine regulation of transcription factor-target interactions in rat striatum. [Review]. Chem Senses 1995; 20: 257-60.
25. Ishida Y, Kuwahara I, Todaka K, Hashiguchi H, Nishimori T, Mitsuyama Y. Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Brain Res 1996; 727: 205-11.
26. Itzhak Y. Cocaine kindling in mice. Responses to N-methyl-D,L-aspartate (NMDLA) and L-arginine. Mol Neurobiol 1995; 11: 217-22.
27. Jentsch JD, Taylor JR. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. [Review], Psychopharmacology (Berl) 1999; 146: 373-90.
28. Konradi C, Leveque JC, Hyman SE. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 1996; 16: 4231-9.
29. Kuhar MJ, Pilotte NS. Neurochemical changes in cocaine withdrawal. [Review]. Trends Pharmacol Sci 1996; 17: 260-4.
30. Liste I, Rozas G, Guerra MJ, Labandeira-Garcia JL. Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors. Brain Res 1995; 700: 1-12.
31. Liu FC, Graybiel AM. Region-dependent dynamics of cAMP response element-binding protein phosphorylation in the basal ganglia, Proc Natl Acad Sci USA 1998; 95: 4708-13.
32. Loftis JM, Janowsky A. Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal. J Neurochem 2000; 75: 2040-50.
33. Moratalla R, Elibol B, Vallejo M, Graybiel AM. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 1996; 17: 147-56.
34. Nguyen TV, Kosofsky BE, Birnbaum R, Cohen BM, Hyman SE. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci USA 1992; 89: 4270-4.
35. Onn SP, West AR, Grace AA. Dopamine-mediated regulation of striatal neuronal and network interactions. [Review]. Trends Neurosci 2000; 23 (10 Suppl): S48-56.
36. Parthasarathy HB, Graybiel AM. Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J Neurosci 1997; 17: 2477-91.
37. Paul ML, Graybiel AM, David JC, Robertson HA. D1-like and D2- like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model in Parkinson's disease. J Neurosci 1992; 12: 3729-42.
38. Rascol O, Sabatini U, Brefel C, Fabre N, Rai S, Senard JM, et al. Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. Brain 1998; 121: 527-33.
39. Reid MS, Berger SP. Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport 1996; 7: 1325-9.
40. Saka E, Elibol B, Erdem S, Dalkara T. Compartmental changes in expression of c-Fos and FosB proteins in intact and dopamine- depleted striatum after chronic apomorphine treatment. Brain Res 1999; 825: 104-14.
41. Schmidt WJ. Dopamine-glutamate interactions in the basal ganglia. [Review]. Amino Acids 1998; 14: 5-10.
42. Self DW, Genova LM, Hope BT, Barnhart WJ, Spencer JJ, Nestler EJ. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaineseeking behavior. J Neurosci 1998; 18: 1848-59.
43. Sgambato V, Abo V, Rogard M, Besson MJ, Deniau JM. Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia. Neuroscience 1997; 81: 93-112.
44. Snyder GL, Allen PB, Fienberg AA, Valle CG, Huganir RL, Nairn AC, et al. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J Neurosci 2000; 20: 4480-8.
45. Steiner H, Gerfen CR. Dynorphin opioid inhibition of cocaine induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J Comp Neurol 1995; 353: 200-12.
46. Vanderschuren LJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. [Review]. Psychopharmacology (Berl) 2000; 151: 99-120,
47. Volkow ND, Fowler JS, Wang GJ, Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans, [Review]. J Psychopharmacol 1999; 13: 337-45.
48. Wolf ME. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. [Review]. Prog Neurobiol 1998; 54: 679-720.
49. Ziemann U, Paulus W, Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 1997; 154: 1277-84.
50. Zigmond MJ, Castro SL, Keefe KA, Abercrombie ED, Sved AF. Role of excitatory amino acids in the regulation of dopamine synthesis and release in the neostriatum. [Review]. Amino Acids 1998; 14: 57-62.